Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets
Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets [...]
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust [...]
Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s Dupixent in eczema
Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s [...]
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging [...]
Emergent BioSolutions founder El-Hibri bids adieu after CDMO’s turbulent 2021
Emergent BioSolutions founder El-Hibri bids adieu after CDMO’s turbulent 2021 [...]
Califf advances in FDA chief nomination process but committee vote indicates he’s no slam-dunk choice
Califf advances in FDA chief nomination process but committee vote [...]
JPM 2022: With Voxzogo approvals adding up, BioMarin is underway with its ‘biggest launch,’ CEO says
JPM 2022: With Voxzogo approvals adding up, BioMarin is underway [...]
Idorsia makes friends with Jen Aniston for new sleep campaign, as it preps for insomnia drug launch
Idorsia makes friends with Jen Aniston for new sleep campaign, [...]
Biogen compiles buyout target list as Aduhelm woe deepens: Stat
Biogen compiles buyout target list as Aduhelm woe deepens: Stat [...]
Bristol Myers plays it safe with first Zeposia TV ad for ulcerative colitis
Bristol Myers plays it safe with first Zeposia TV ad [...]